HIGHLIGHTS
- who: Huazhen Liu and collaborators from the Carol Davila University of Medicine and Nuclear Medicine, China have published the research: Case Report: Life-threatening hypercalcemia associated with MMR-deficient endometrial carcinoma secreting parathyroid hormone, in the Journal: (JOURNAL)
SUMMARY
Hypercalcemia occurs in 20-30% of cancer patients during the disease course. The most common cause of malignancy-associated hypercalcemia (MAH) was humoral hypercalcemia of malignancy caused by PTHrP (parathyroid hormone (PTH)-related protein) with a frequency of 80%, while the rarest cause being an ectopic secretion of PTH by malignancy ( and amp;lt . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.